Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surong Chen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Dentistry|November 4, 2025
Deep learning super-resolution for dental CBCT using micro-CT reference and edge loss functionPan Chen, Bowen Shen, Yan Yang, et al.
International Endodontic Journal|February 23, 2026
Transfer Learning From Micro-CT to Periapical Radiographs for Three-Dimensional Root Canal Morphological IdentificationWeiwei Wu, Jingyu Hu, Bowen Shen, et al.
Eclinicalmedicine|November 29, 2023
Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinomaSheng Li, Jun Bao, Xiaoyou Li, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Dentistry|November 4, 2025
Deep learning super-resolution for dental CBCT using micro-CT reference and edge loss functionPan Chen, Bowen Shen, Yan Yang, et al.
International Endodontic Journal|February 23, 2026
Transfer Learning From Micro-CT to Periapical Radiographs for Three-Dimensional Root Canal Morphological IdentificationWeiwei Wu, Jingyu Hu, Bowen Shen, et al.
Eclinicalmedicine|November 29, 2023
Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinomaSheng Li, Jun Bao, Xiaoyou Li, et al.
Pageof 2